Has Ankur Khosla, MD received payments from drug or device companies?

Yes. Drug and device makers reported $511,074 in general payments to Ankur Khosla, MD across 1,040 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ankur Khosla, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ankur Khosla, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ankur Khosla, MD

Interventional Pain Medicine · Shenandoah, TXNPI 1861760985

Payments from drug & device makers

$511,074in general payments, 2019–2025

Across 1,040 payments — averaging $491.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Spinal Simplicity, LLC$288K
Abbott$79K
Surgentec$71K
Averitas Pharma Inc.$31K
Boston Scientific$19K
Painteq LLC$4K
plus $19K from 36 others

What the payments were for

Royalty or licence$30,72611%
Consulting fees$90,25433%
Speaking & faculty fees$78,96829%
Travel & lodging$39,36014%
Food & beverage$31,54211%
Education$6,1492%
Entertainment$770%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Spinal Simplicity, LLC	121	$288,164
Abbott	378	$78,998
Surgentec	11	$70,830
Averitas Pharma Inc.	59	$30,510
Boston Scientific	79	$19,067
Painteq LLC	38	$4,317
GRT US Holding, Inc.	12	$2,584
Si-bone, Inc.	26	$2,254
Medtronic(2 entities)	34	$2,201
Nevro Corp.	22	$1,663
Relievant Medsystems, Inc.	15	$1,437
Vertiflex, Inc.	8	$1,301
Vertos Medical, Inc.	8	$1,228
AbbVie(2 entities)	83	$1,115
Pacira Pharmaceuticals Incorporated	6	$841
Globus Medical	13	$694
Spinefrontier, Inc.	3	$495
Foundation Fusion Solutions, LLC	7	$486
Saluda Medical Americas, Inc.	7	$428
SPR Therapeutics, Inc	9	$332
Biotissue Holdings Inc.	8	$326
Arbor Pharmaceuticals, Inc.	32	$269
Azurity Pharmaceuticals, Inc.	11	$238
Nalu Medical, Inc.	4	$223
Stimwave Technologies Incorporated	3	$146
Lundbeck LLC	7	$135
Pacira Therapeutics, Inc.	5	$91
Almatica Pharma LLC	5	$90
Amgen(2 entities)	4	$85
Flowonix Medical Incorporated	1	$79
Vertex	3	$76
Biodelivery Sciences International, Inc.	5	$64
Axsome Therapeutics, Inc.	2	$53
Pfizer	2	$48
Biotronik NRO, Inc.	1	$46
Avanos Medical	1	$37
Teva Pharmaceuticals USA, Inc.	2	$34
Kyowa Kirin, Inc.	1	$23
Zyla Life Sciences, Inc.	1	$20
Ultragenyx Pharmaceutical Inc.	1	$20
Scilex Pharmaceuticals Inc.	1	$16
Lilly USA, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROCLAIM$61,012
TiLink$60,797
HA MINUTEMAN G3-R$52,218
Qutenza$32,455
ION$11,784
SUPERION$10,672
ION Facet Screw System$8,822
GENERAL PAIN MANAGEMENT$6,897
Proclaim IPG$5,910
3D GraftRasp System$5,663
ION Facet Screw$4,313
PAINTEQ$3,451
Intracept$2,185
Proclaim Family of SCS IPGs$2,000
iFuse Implant$1,610
INTELLIS$1,198
Superion ISS$1,122
Senza Spinal Cord Stimulation System$1,075
mild Device Kit$1,007
Neuromodulation Dspsbls and Accs$992

How this compares

$511,074 in reported general payments places this provider in the 95th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$1,181,484

Medicare patients

553

Services billed

52,866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Potassium	38	$61,478
Cephalexin	226	$4,689
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	297	$2,939
Tizanidine Hcl	420	$1,514
Gabapentin	176	$1,350
Diclofenac Sodium	22	$341
Cyclobenzaprine Hcl	42	$213
Clindamycin Hcl	12	$88
Tramadol Hcl	17	$84
Meloxicam	39	$83
Methylprednisolone	12	$67

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Shenandoah

Thomas WhiteShenandoah$183K
Yoann MilletShenandoah$22K
Kenneth WuShenandoah$22K
Gabor RaczLubbock$3M
Pankaj MehtaKilleen$2.2M
Genaro GutierrezAustin$1.3M
Chad StephensSouthlake$1.1M
Ioannis SkaribasHouston$979K
Duane GriffithTyler$730K
Brannon FrankAustin$698K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →